{"nct_id":"NCT02360475","title":"Safety, Reactogenicity and Immunogenicity Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals' Investigational RSV Vaccine (GSK3003891A), in Healthy Women","status":"COMPLETED","status_verified_date":"2018-05","start_date":"2015-03-20","start_date_type":"ACTUAL","primary_completion_date":"2015-07-02","primary_completion_date_type":"ACTUAL","completion_date":"2016-06-21","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["GSK"]}